XML 45 R34.htm IDEA: XBRL DOCUMENT
v3.25.1

Consolidated Schedule of Investments (Unaudited) - Investments (Details) - USD ($) | Mar. 31, 2025 | Dec. 31, 2024 | Mar. 31, 2024 | Dec. 31, 2023
--- | --- | --- | --- | ---
Investments at cost | $ 790,592,000 | $ 766,774,000 |  |
Investments at fair value | 689,553,000 | 697,891,000 |  |
Unrestricted Short Term Investments [Member] |  |  |  |
Investments at cost | 40,968,000 | 27,266,000 |  |
Investments at fair value | 40,968,000 | 27,266,000 |  |
Restricted Short Term Investments [Member] |  |  |  |
Investments at cost | 3,463,000 | 3,338,000 |  |
Investments at fair value | 3,463,000 | 3,338,000 |  |
Equity Securities [Member] |  |  |  |
Investments at cost | 37,988,000 | 35,942,000 |  |
Investments at fair value | 13,686,000 | 26,198,000 |  |
Warrant [Member] |  |  |  |
Investments at cost | 16,120,000 | 15,956,000 |  |
Investments at fair value | 18,603,000 | 18,277,000 |  |
U S Bank Money Market Deposit Account [Member] | Unrestricted Short Term Investments [Member] |  |  |  |
Investments at cost | 40,968,000 | 27,266,000 |  |
Investments at fair value | 40,968,000 | 27,266,000 |  |
U S Bank Money Market Deposit Account [Member] | Restricted Short Term Investments [Member] |  |  |  |
Investments at cost | 3,463,000 | 3,338,000 |  |
Investments at fair value | 3,463,000 | 3,338,000 |  |
Medical Device Sector [Member] |  |  |  |
Investments at cost | 220,360,000 | 213,564,000 |  |
Investments at fair value | 192,105,000 | 205,634,000 |  |
Software Sector [Member] |  |  |  |
Investments at cost | 161,916,000 | 154,040,000 |  |
Investments at fair value | 159,213,000 | 151,043,000 |  |
Biotechnology Sector [Member] |  |  |  |
Investments at cost | 138,360,000 | 118,221,000 |  |
Investments at fair value | 116,174,000 | 97,562,000 |  |
Other Sustainability Sector [Member] |  |  |  |
Investments at cost | 65,329,000 | 66,151,000 |  |
Investments at fair value | 64,109,000 | 66,079,000 |  |
Energy Efficiency [Member] |  |  |  |
Investments at cost | 9,824,000 | 9,818,000 |  |
Investments at fair value | 9,713,000 | 9,712,000 |  |
Other Healthcare Sector [Member] |  |  |  |
Investments at cost | 39,552,000 | 39,533,000 |  |
Investments at fair value | 40,166,000 | 40,144,000 |  |
Networking Sector [Member] |  |  |  |
Investments at cost | 10,076,000 | 10,070,000 |  |
Investments at fair value | 9,826,000 | 9,827,000 |  |
Diagnostics Sector [Member] |  |  |  |
Investments at cost | 17,252,000 | 16,704,000 |  |
Investments at fair value | 14,661,000 | 13,701,000 |  |
Communications Sector [Member] |  |  |  |
Investments at cost | 518,000 | 11,711,000 |  |
Investments at fair value | 3,547,000 | 14,763,000 |  |
Investment, Unaffiliated Issuer [Member] |  |  |  |
Investments at cost | 715,151,000 | 694,503,000 |  |
Investments at fair value | 666,377,000 | 657,765,000 |  |
Investment, Unaffiliated Issuer [Member] | Equity Securities [Member] |  |  |  |
Investments at cost | 9,699,000 | 9,653,000 |  |
Investments at fair value | 5,776,000 | 8,277,000 |  |
Investment, Unaffiliated Issuer [Member] | Warrant [Member] |  |  |  |
Investments at cost | 15,993,000 | 15,829,000 |  |
Investments at fair value | 18,603,000 | 18,277,000 |  |
Investment, Unaffiliated Issuer [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 680,982,000 | 660,556,000 |  |
Investments at fair value | 641,898,000 | 631,111,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Investments [Member] |  |  |  |
Investments at cost | 8,477,000 | 8,465,000 |  |
Investments at fair value | 100,000 | 100,000 |  |
Investment, Unaffiliated Issuer [Member] | Castle Creek Biosciences, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 250,000 | 250,000 |  |
Investments at fair value | $ 250,000 | $ 250,000 |  |
Number of Shares (in shares) | 1,162 | 1,162 |  |
Investment, Unaffiliated Issuer [Member] | Emalex Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 402,000 | $ 356,000 |  |
Investments at fair value | $ 512,000 | $ 356,000 |  |
Number of Shares (in shares) | 37,017 | 32,831 |  |
Investment, Unaffiliated Issuer [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 89,000 | $ 89,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 2,688,971 | 2,688,971 |  |
Investment, Unaffiliated Issuer [Member] | Axiom Space, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 261,000 | $ 261,000 |  |
Investments at fair value | $ 306,000 | $ 306,000 |  |
Number of Shares (in shares) | 1,810 | 1,810 |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 487,000 | $ 487,000 |  |
Investments at fair value | $ 487,000 | $ 487,000 |  |
Number of Shares (in shares) | 8,123,877 | 8,123,877 |  |
Investment, Unaffiliated Issuer [Member] | Cognoa, Inc. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 250,000 | $ 250,000 |  |
Investments at fair value | $ 250,000 | $ 250,000 |  |
Number of Shares (in shares) | 1,059,636 | 1,059,636 |  |
Investment, Unaffiliated Issuer [Member] | Lumithera, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 2,000,000 | $ 2,000,000 |  |
Investments at fair value | $ 1,700,000 | $ 1,700,000 |  |
Number of Shares (in shares) | 392,651 | 392,651 |  |
Investment, Unaffiliated Issuer [Member] | Cadrenal Therapeutics, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 0 | $ 0 |  |
Investments at fair value | $ 705,000 | $ 580,000 |  |
Number of Shares (in shares) | 40,000 | 40,000 |  |
Investment, Unaffiliated Issuer [Member] | PebblePost, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 73,000 | $ 73,000 |  |
Investments at fair value | $ 73,000 | $ 73,000 |  |
Number of Shares (in shares) | 56,212 | 56,212 |  |
Investment, Unaffiliated Issuer [Member] | Caastle, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 2,681,000 | $ 2,681,000 |  |
Investments at fair value | $ 0 | $ 2,681,000 |  |
Number of Shares (in shares) | 242,180 | 242,180 |  |
Investment, Unaffiliated Issuer [Member] | Getaround, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 253,000 | $ 253,000 |  |
Investments at fair value | $ 3,000 | $ 3,000 |  |
Number of Shares (in shares) | 87,082 | 87,082 |  |
Investment, Unaffiliated Issuer [Member] | SnagAJob.com, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 9,000 | $ 9,000 |  |
Investments at fair value | $ 0 | $ 83,000 |  |
Number of Shares (in shares) | 82,974 | 82,974 |  |
Investment, Unaffiliated Issuer [Member] | Tigo Energy, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | $ 111,000 | $ 111,000 |  |
Investments at fair value | $ 4,000 | $ 5,000 |  |
Number of Shares (in shares) | 5,205 | 5,205 |  |
Investment, Unaffiliated Issuer [Member] | Decisyon, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 2,800,000 | $ 2,800,000 |  |
Investments at fair value | $ 1,281,000 | $ 1,281,000 |  |
Number of Shares (in shares) | 280,000 | 280,000 |  |
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 4,000 | $ 4,000 |  |
Investments at fair value | $ 179,000 | $ 193,000 |  |
Number of Shares (in shares) | 66,127 | 66,127 |  |
Investment, Unaffiliated Issuer [Member] | Lotame Solutions, Inc. [Member] | Preferred Stock 2 [Member] |  |  |  |
Investments at cost | $ 29,000 | $ 29,000 |  |
Investments at fair value | $ 26,000 | $ 29,000 |  |
Number of Shares (in shares) | 9,381 | 9,381 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | $ 263,280,000 |  |
Investments at fair value |  | 261,520,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 147,000 | 147,000 |  |
Investments at fair value | $ 972,000 | $ 1,573,000 |  |
Number of Shares (in shares) | 89,903 | 89,903 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 10.25% | 10.25% |  |
Margin | 2.75% | 2.75% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Mar. 01, 2029 | Mar. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,823,000 | 4,820,000 |  |
Investments at fair value | $ 4,823,000 | $ 4,820,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 10.25% | 10.25% |  |
Margin | 2.75% | 2.75% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP |  | 4.00% |  |
Maturity Date | Mar. 01, 2029 | Mar. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,944,000 | 4,941,000 |  |
Investments at fair value | $ 4,944,000 | $ 4,941,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Ceribell, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 10.25% | 10.25% |  |
Margin | 2.75% | 2.75% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Mar. 01, 2029 | Mar. 01, 2029 |  |
Principal Amount | $ 4,000,000 | $ 4,000,000 |  |
Investments at cost | 3,955,000 | 3,952,000 |  |
Investments at fair value | 3,955,000 | $ 3,952,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 11.50% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 5,000,000 |  |
Investments at cost |  | 4,785,000 |  |
Investments at fair value |  | 4,785,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 152,000 | 152,000 |  |
Investments at fair value | $ 76,000 | $ 78,000 |  |
Number of Shares (in shares) | 93,336 | 93,336 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate |  | 11.50% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP | 4.00% | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,468,000 |  |
Investments at fair value |  | $ 2,468,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Candesant Biomedical, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate |  | 11.50% |  |
Margin |  | 3.50% |  |
Floor |  | 11.50% |  |
Ceiling |  | 0.00% |  |
ETP |  | 5.00% |  |
Maturity Date |  | Sep. 01, 2027 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,468,000 |  |
Investments at fair value |  | $ 2,468,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 15,000,000 | $ 15,000,000 |  |
Investments at cost | 14,752,000 | 14,735,000 |  |
Investments at fair value | $ 14,752,000 | $ 14,735,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,834,000 | 9,823,000 |  |
Investments at fair value | $ 9,834,000 | $ 9,823,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,916,000 | 4,912,000 |  |
Investments at fair value | $ 4,916,000 | $ 4,912,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | VERO Biotech LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,458,000 | 2,456,000 |  |
Investments at fair value | $ 2,458,000 | $ 2,456,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,702,000 | 3,699,000 |  |
Investments at fair value | $ 3,702,000 | $ 3,699,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MicroTransponder, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,702,000 | 3,699,000 |  |
Investments at fair value | 3,702,000 | 3,699,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 256,000 | 256,000 |  |
Investments at fair value | $ 29,000 | $ 102,000 |  |
Number of Shares (in shares) | 9,313,541 | 9,313,541 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.32% | 12.32% |  |
Margin | 4.82% | 4.82% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 10.36% | 10.36% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 2,897,000 | $ 3,187,000 |  |
Investments at cost | 2,888,000 | 3,168,000 |  |
Investments at fair value | $ 2,888,000 | $ 3,168,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Conventus Orthopaedics, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.32% | 12.32% |  |
Margin | 4.82% | 4.82% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 10.36% | 10.36% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 2,897,000 | $ 3,187,000 |  |
Investments at cost | 2,888,000 | 3,168,000 |  |
Investments at fair value | $ 2,888,000 | $ 3,168,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 10.75% | 10.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 10.75% | 10.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2030 | Jan. 01, 2030 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,825,000 | 9,818,000 |  |
Investments at fair value | $ 9,825,000 | $ 9,818,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 10.75% | 10.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 10.75% | 10.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2030 | Jan. 01, 2030 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,852,000 | 9,845,000 |  |
Investments at fair value | $ 9,852,000 | $ 9,845,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 10.75% | 10.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 10.75% | 10.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2030 | Jan. 01, 2030 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,926,000 | 4,923,000 |  |
Investments at fair value | $ 4,926,000 | $ 4,923,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Onkos Surgical, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 10.75% | 10.75% |  |
Margin | 3.25% | 3.25% |  |
Floor | 10.75% | 10.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2030 | Jan. 01, 2030 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,926,000 | 4,923,000 |  |
Investments at fair value | $ 4,926,000 | $ 4,923,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.50% |  |
Margin | 4.75% | 4.75% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,738,000 | 3,735,000 |  |
Investments at fair value | $ 3,738,000 | $ 3,735,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.50% |  |
Margin | 4.75% | 4.75% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,738,000 | 3,735,000 |  |
Investments at fair value | $ 3,738,000 | $ 3,735,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.75% | 13.00% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,969,000 | 4,964,000 |  |
Investments at fair value | $ 4,969,000 | $ 4,964,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Scientia Vascular, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.75% | 13.00% |  |
Margin | 5.25% | 5.25% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,947,000 | 4,937,000 |  |
Investments at fair value | 4,947,000 | 4,937,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 231,000 | 231,000 |  |
Investments at fair value | $ 170,000 | $ 175,000 |  |
Number of Shares (in shares) | 5,361,130 | 5,361,130 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.25% |  |
Margin | 4.50% | 4.50% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Sep. 01, 2029 | Sep. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,924,000 | 4,920,000 |  |
Investments at fair value | $ 4,924,000 | $ 4,920,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.25% |  |
Margin | 4.50% | 4.50% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Sep. 01, 2029 | Sep. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,924,000 | 4,920,000 |  |
Investments at fair value | $ 4,924,000 | $ 4,920,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | InfoBionic, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.25% |  |
Margin | 4.50% | 4.50% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Sep. 01, 2029 | Sep. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,924,000 | 4,920,000 |  |
Investments at fair value | $ 4,924,000 | $ 4,920,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,482,000 | 2,480,000 |  |
Investments at fair value | $ 2,482,000 | $ 2,480,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,482,000 | 2,480,000 |  |
Investments at fair value | $ 2,482,000 | $ 2,480,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,965,000 | 4,961,000 |  |
Investments at fair value | $ 4,965,000 | $ 4,961,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Sep. 01, 2027 | Sep. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,965,000 | 4,961,000 |  |
Investments at fair value | $ 4,965,000 | $ 4,961,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,716,000 | 3,714,000 |  |
Investments at fair value | $ 3,716,000 | $ 3,714,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,716,000 | 3,714,000 |  |
Investments at fair value | $ 3,716,000 | $ 3,714,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,716,000 | 3,714,000 |  |
Investments at fair value | $ 3,716,000 | $ 3,714,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Sonex Health, Inc. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 8.00% | 8.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,716,000 | 3,714,000 |  |
Investments at fair value | $ 3,716,000 | $ 3,714,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,920,000 | 4,916,000 |  |
Investments at fair value | $ 4,920,000 | $ 4,916,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 4,250,000 | $ 4,250,000 |  |
Investments at cost | 4,182,000 | 4,178,000 |  |
Investments at fair value | $ 4,182,000 | $ 4,178,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 4,250,000 | $ 4,250,000 |  |
Investments at cost | 4,182,000 | 4,178,000 |  |
Investments at fair value | $ 4,182,000 | $ 4,178,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Spineology, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 1.00% | 1.00% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,460,000 | 2,458,000 |  |
Investments at fair value | $ 2,460,000 | 2,458,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 10.50% |  |  |
Margin | 3.00% |  |  |
Floor | 10.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 3.00% |  |  |
Maturity Date | Mar. 01, 2030 |  |  |
Principal Amount | $ 2,507,000 |  |  |
Investments at cost | 2,282,000 |  |  |
Investments at fair value | $ 2,282,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 10.50% |  |  |
Margin | 3.00% |  |  |
Floor | 10.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 3.00% |  |  |
Maturity Date | Mar. 01, 2030 |  |  |
Principal Amount | $ 2,507,000 |  |  |
Investments at cost | 2,482,000 |  |  |
Investments at fair value | $ 2,482,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 10.50% |  |  |
Margin | 3.00% |  |  |
Floor | 10.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 3.00% |  |  |
Maturity Date | Mar. 01, 2030 |  |  |
Principal Amount | $ 5,013,000 |  |  |
Investments at cost | 4,964,000 |  |  |
Investments at fair value | $ 4,964,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | MML US, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 10.50% |  |  |
Margin | 3.00% |  |  |
Floor | 10.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 3.00% |  |  |
Maturity Date | Mar. 01, 2030 |  |  |
Principal Amount | $ 5,013,000 |  |  |
Investments at cost | 4,964,000 |  |  |
Investments at fair value | 4,964,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | AccuVein Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 7,000 | 7,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 271 | 271 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerin Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 65,000 | $ 65,000 |  |
Investments at fair value | $ 1,350,000 | $ 1,418,000 |  |
Number of Shares (in shares) | 1,818,183 | 1,818,183 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 9.00% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 18.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 2,500,000 |  |  |
Investments at cost | 2,482,000 |  |  |
Investments at fair value | 1,816,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 48,000 | $ 48,000 |  |
Investments at fair value | $ 0 | $ 16,000 |  |
Number of Shares (in shares) | 8,800 | 8,800 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 9.00% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 18.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 2,500,000 |  |  |
Investments at cost | 2,482,000 |  |  |
Investments at fair value | $ 1,816,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 9.00% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 18.00% |  |  |
Maturity Date | Apr. 01, 2028 |  |  |
Principal Amount | $ 200,000 |  |  |
Investments at cost | 192,000 |  |  |
Investments at fair value | 140,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,480,000 |  |
Investments at fair value |  | $ 2,085,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 200,000 |  |
Investments at cost |  | 190,000 |  |
Investments at fair value |  | $ 160,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Aerobiotix, LLC [Member] | Term Loan, Fixed Index One [Member] |  |  |  |
Cash Rate |  | 9.00% |  |
Margin |  | 0.00% |  |
Floor |  | 0.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 18.00% |  |
Maturity Date |  | Apr. 01, 2028 |  |
Principal Amount |  | $ 2,500,000 |  |
Investments at cost |  | 2,480,000 |  |
Investments at fair value |  | 2,085,000 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Canary Medical Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 86,000 | 86,000 |  |
Investments at fair value | $ 1,000 | $ 2,000 |  |
Number of Shares (in shares) | 12,153 | 12,153 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 0 | $ 0 |  |
Investments at fair value | $ 2,000 | $ 2,000 |  |
Number of Shares (in shares) | 30,585 | 30,585 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | Cognoa, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 162,000 | $ 162,000 |  |
Investments at fair value | $ 1,000 | $ 1,000 |  |
Number of Shares (in shares) | 4,635,991 | 4,635,991 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CSA Medical, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 174,000 | $ 174,000 |  |
Investments at fair value | $ 471,000 | $ 479,000 |  |
Number of Shares (in shares) | 4,939,813 | 4,917,794 |  |
Investment, Unaffiliated Issuer [Member] | Medical Device Sector [Member] | CVRx, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 76,000 | $ 76,000 |  |
Investments at fair value | $ 140,000 | $ 160,000 |  |
Number of Shares (in shares) | 47,410 | 47,410 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 5.00% | 5.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 10.40% | 10.40% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 1,778,000 | $ 2,000,000 |  |
Investments at cost | 1,437,000 | 1,568,000 |  |
Investments at fair value | $ 1,437,000 | $ 1,568,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 5.00% | 5.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 10.40% | 10.40% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 2,667,000 | $ 3,000,000 |  |
Investments at cost | 2,277,000 | 2,529,000 |  |
Investments at fair value | $ 2,277,000 | $ 2,529,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.00% | 11.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 10.50% | 10.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 7.78% | 7.78% |  |
Maturity Date | Feb. 01, 2028 | Feb. 01, 2028 |  |
Principal Amount | $ 2,813,000 | $ 2,813,000 |  |
Investments at cost | 2,813,000 | 2,813,000 |  |
Investments at fair value | $ 2,813,000 | $ 2,813,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Havenly, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.00% | 11.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 10.50% | 10.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 7.78% | 7.78% |  |
Maturity Date | Feb. 01, 2028 | Feb. 01, 2028 |  |
Principal Amount | $ 2,813,000 | $ 2,813,000 |  |
Investments at cost | 2,813,000 | 2,813,000 |  |
Investments at fair value | $ 2,813,000 | $ 2,813,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Lyrical Foods, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.00% | 11.00% |  |
Margin | 3.50% | 3.50% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jul. 01, 2028 | Jul. 01, 2028 |  |
Principal Amount | $ 2,679,000 | $ 2,679,000 |  |
Investments at cost | 2,769,000 | 2,768,000 |  |
Investments at fair value | $ 2,418,000 | $ 2,405,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 6,204,000 | $ 6,042,000 |  |
Investments at cost | 5,375,000 | 5,415,000 |  |
Investments at fair value | $ 1,258,000 | $ 1,271,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 2,482,000 | $ 3,021,000 |  |
Investments at cost | 2,687,000 | 2,707,000 |  |
Investments at fair value | $ 630,000 | $ 635,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 3,102,000 | $ 2,417,000 |  |
Investments at cost | 2,150,000 | 2,166,000 |  |
Investments at fair value | $ 504,000 | $ 508,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 3,722,000 | $ 3,021,000 |  |
Investments at cost | 2,687,000 | 2,707,000 |  |
Investments at fair value | $ 630,000 | $ 635,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 3,102,000 | $ 3,625,000 |  |
Investments at cost | 3,225,000 | 3,249,000 |  |
Investments at fair value | $ 756,000 | $ 762,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 3,102,000 | $ 3,021,000 |  |
Investments at cost | 2,687,000 | 2,707,000 |  |
Investments at fair value | $ 630,000 | $ 635,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 6,204,000 | $ 6,042,000 |  |
Investments at cost | 5,375,000 | 5,415,000 |  |
Investments at fair value | $ 1,259,000 | $ 1,271,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | NextCar Holding Company, Inc [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 13.25% | 13.50% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.25% | 5.25% |  |
Maturity Date | Oct. 31, 2023 | Oct. 31, 2023 |  |
Principal Amount | $ 3,102,000 | $ 3,021,000 |  |
Investments at cost | 2,686,000 | 2,707,000 |  |
Investments at fair value | $ 629,000 | $ 635,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.75% | 14.00% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,456,000 | 2,448,000 |  |
Investments at fair value | $ 2,456,000 | $ 2,448,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Optoro, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.75% | 14.00% |  |
Margin | 6.25% | 6.25% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jul. 01, 2028 | Jul. 01, 2028 |  |
Principal Amount | $ 1,875,000 | $ 1,875,000 |  |
Investments at cost | 1,811,000 | 1,805,000 |  |
Investments at fair value | $ 1,811,000 | $ 1,805,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.75% | 12.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,343,000 | 2,339,000 |  |
Investments at fair value | $ 0 | $ 2,267,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.75% | 12.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,430,000 | 2,426,000 |  |
Investments at fair value | $ 0 | $ 2,352,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Standvast Holdings, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.75% | 12.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Nov. 01, 2028 | Nov. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,421,000 | 2,417,000 |  |
Investments at fair value | $ 0 | $ 2,343,000 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 7.75% | 7.75% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 1,470,000 | $ 1,415,000 |  |
Investments at cost | 1,086,000 | 1,086,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 7.75% | 7.75% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 735,000 | $ 708,000 |  |
Investments at cost | 543,000 | 543,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Investment, Unaffiliated Issuer [Member] | Consumer-related Technologies [Member] | Unagi, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 15.25% | 15.25% |  |
Margin | 7.75% | 7.75% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | May 01, 2027 | May 01, 2027 |  |
Principal Amount | $ 735,000 | $ 708,000 |  |
Investments at cost | 543,000 | 543,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,968,000 | 9,977,000 |  |
Investments at fair value | $ 9,968,000 | $ 9,977,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,968,000 | 9,955,000 |  |
Investments at fair value | $ 9,968,000 | $ 9,955,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,984,000 | 4,978,000 |  |
Investments at fair value | $ 4,984,000 | $ 4,978,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Kodiak Robotics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 10.25% | 10.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,984,000 | 4,978,000 |  |
Investments at fair value | $ 4,984,000 | $ 4,978,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,939,000 | 9,928,000 |  |
Investments at fair value | $ 9,939,000 | $ 9,928,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,970,000 | 4,964,000 |  |
Investments at fair value | $ 4,970,000 | $ 4,964,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Noodle Partners, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.50% | 12.50% |  |
Margin | 5.00% | 5.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Mar. 01, 2027 | Mar. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,970,000 | 4,964,000 |  |
Investments at fair value | $ 4,970,000 | $ 4,964,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.00% | 13.25% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 7,000,000 | $ 7,000,000 |  |
Investments at cost | 6,962,000 | 6,954,000 |  |
Investments at fair value | $ 6,962,000 | $ 6,954,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.00% | 13.25% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 3,500,000 | $ 3,500,000 |  |
Investments at cost | 3,480,000 | 3,477,000 |  |
Investments at fair value | $ 3,480,000 | $ 3,477,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 13.00% | 13.25% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 3,500,000 | $ 3,500,000 |  |
Investments at cost | 3,480,000 | 3,477,000 |  |
Investments at fair value | $ 3,480,000 | $ 3,477,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | BrightInsight, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.00% | 13.25% |  |
Margin | 5.50% | 5.50% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 2,750,000 | $ 2,750,000 |  |
Investments at cost | 2,723,000 | 2,719,000 |  |
Investments at fair value | $ 2,723,000 | $ 2,719,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.25% | 11.125% |  |
Margin | 3.75% | 3.625% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Jan. 01, 2030 | Jan. 01, 2030 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,449,000 | 2,448,000 |  |
Investments at fair value | $ 2,449,000 | $ 2,448,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.25% | 11.125% |  |
Margin | 3.75% | 3.625% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Jan. 01, 2030 | Jan. 01, 2030 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,475,000 | 2,474,000 |  |
Investments at fair value | $ 2,475,000 | $ 2,474,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,939,000 | 4,934,000 |  |
Investments at fair value | $ 4,939,000 | $ 4,934,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,939,000 | 4,934,000 |  |
Investments at fair value | $ 4,939,000 | $ 4,934,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,939,000 | 4,934,000 |  |
Investments at fair value | $ 4,939,000 | $ 4,934,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Mirantis, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,939,000 | 4,934,000 |  |
Investments at fair value | $ 4,939,000 | $ 4,934,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 10,000,000 | $ 10,000,000 |  |
Investments at cost | 9,901,000 | 9,890,000 |  |
Investments at fair value | $ 9,901,000 | $ 9,890,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,950,000 | 4,945,000 |  |
Investments at fair value | $ 4,950,000 | $ 4,945,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,950,000 | 4,945,000 |  |
Investments at fair value | $ 4,950,000 | $ 4,945,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Elligo Healthcare Research, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 3.50% | 3.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2027 | Oct. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,950,000 | 4,945,000 |  |
Investments at fair value | $ 4,950,000 | $ 4,945,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Ursa Space Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.00% | 4.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Nov. 01, 2028 | Nov. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,369,000 | 2,365,000 |  |
Investments at fair value | $ 2,369,000 | $ 2,365,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Ursa Space Systems Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.00% | 4.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Nov. 01, 2028 | Nov. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,445,000 | 2,440,000 |  |
Investments at fair value | $ 2,445,000 | $ 2,440,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 4.00% | 4.00% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 4,500,000 | $ 4,833,000 |  |
Investments at cost | 4,464,000 | 4,791,000 |  |
Investments at fair value | $ 4,464,000 | $ 4,791,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 4.00% | 4.00% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 2,250,000 | $ 2,417,000 |  |
Investments at cost | 2,232,000 | 2,396,000 |  |
Investments at fair value | $ 2,232,000 | $ 2,396,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Viken Detection Corporation [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.75% | 11.75% |  |
Margin | 4.00% | 4.00% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 2,250,000 | $ 2,417,000 |  |
Investments at cost | 2,232,000 | 2,396,000 |  |
Investments at fair value | $ 2,232,000 | $ 2,396,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.00% | 11.00% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,879,000 | 4,872,000 |  |
Investments at fair value | $ 4,879,000 | $ 4,872,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | SafelyYou, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.00% | 11.00% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.00% | 11.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jun. 01, 2027 | Jun. 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,953,000 | 4,945,000 |  |
Investments at fair value | $ 4,953,000 | $ 4,945,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,415,000 | 2,414,000 |  |
Investments at fair value | $ 2,415,000 | $ 2,414,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 3,500,000 | $ 3,500,000 |  |
Investments at cost | 3,492,000 | 3,492,000 |  |
Investments at fair value | $ 3,492,000 | $ 3,492,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,494,000 | 2,494,000 |  |
Investments at fair value | $ 2,494,000 | $ 2,494,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 1,500,000 | $ 1,500,000 |  |
Investments at cost | 1,497,000 | 1,496,000 |  |
Investments at fair value | $ 1,497,000 | $ 1,496,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Supply Network Visibility Holdings, LLC [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Jul. 01, 2029 | Jul. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,985,000 | 4,984,000 |  |
Investments at fair value | $ 4,985,000 | $ 4,984,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,948,000 | 4,909,000 |  |
Investments at fair value | $ 4,948,000 | $ 4,909,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,474,000 | 2,472,000 |  |
Investments at fair value | $ 2,474,000 | $ 2,472,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,474,000 | 2,472,000 |  |
Investments at fair value | $ 2,474,000 | $ 2,472,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Oct. 01, 2028 | Oct. 01, 2028 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,474,000 | 2,472,000 |  |
Investments at fair value | $ 2,474,000 | $ 2,472,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 14.00% | 14.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Apr. 01, 2029 | Apr. 01, 2029 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,471,000 | 2,469,000 |  |
Investments at fair value | $ 2,471,000 | $ 2,469,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Britecore Holdings, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 14.00% |  |  |
Margin | 5.50% |  |  |
Floor | 14.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 3.00% |  |  |
Maturity Date | Feb. 01, 2030 |  |  |
Principal Amount | $ 2,500,000 |  |  |
Investments at cost | 2,465,000 |  |  |
Investments at fair value | $ 2,465,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.50% | 4.50% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,851,000 | 4,846,000 |  |
Investments at fair value | $ 4,851,000 | $ 4,846,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.50% | 4.50% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,916,000 | 4,911,000 |  |
Investments at fair value | $ 4,916,000 | $ 4,911,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | Crafty Holdings, Inc.[Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.50% | 4.50% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,916,000 | 4,911,000 |  |
Investments at fair value | $ 4,916,000 | $ 4,911,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 6,804,000 | $ 6,804,000 |  |
Investments at cost | 6,752,000 | 6,740,000 |  |
Investments at fair value | $ 6,440,000 | $ 6,362,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 6,280,000 | $ 6,280,000 |  |
Investments at cost | 6,233,000 | 6,221,000 |  |
Investments at fair value | $ 5,943,000 | $ 5,872,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | DropOff, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 14.00% | 14.00% |  |
Margin | 6.50% | 6.50% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 2,617,000 | $ 2,617,000 |  |
Investments at cost | 2,599,000 | 2,595,000 |  |
Investments at fair value | $ 2,479,000 | 2,449,000 |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.50% |  |  |
Margin | 4.00% |  |  |
Floor | 11.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 2.75% |  |  |
Maturity Date | Feb. 01, 2030 |  |  |
Principal Amount | $ 3,000,000 |  |  |
Investments at cost | 2,913,000 |  |  |
Investments at fair value | $ 2,913,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Software Sector [Member] | HappyCo, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.50% |  |  |
Margin | 4.00% |  |  |
Floor | 11.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 2.75% |  |  |
Maturity Date | Feb. 01, 2030 |  |  |
Principal Amount | $ 3,000,000 |  |  |
Investments at cost | 2,965,000 |  |  |
Investments at fair value | 2,965,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Avalo Therapeutics, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 311,000 | 311,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 117 | 117 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.88% |  |
Margin | 4.25% | 5.13% |  |
Floor | 12.00% |  |  |
Ceiling | 0.00% | 13.50% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2028 | May 01, 2026 |  |
Principal Amount | $ 10,000,000 | $ 3,333,000 |  |
Investments at cost | 9,927,000 | 3,326,000 |  |
Investments at fair value | 9,927,000 | 3,326,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 279,000 | 214,000 |  |
Investments at fair value | $ 258,000 | $ 270,000 |  |
Number of Shares (in shares) | 9,775 | 7,404 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.88% |  |
Margin | 4.25% | 5.13% |  |
Floor | 12.00% | 9.55% |  |
Ceiling | 0.00% | 13.50% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2028 | May 01, 2026 |  |
Principal Amount | $ 5,500,000 | $ 3,333,000 |  |
Investments at cost | 5,460,000 | 3,326,000 |  |
Investments at fair value | $ 5,460,000 | $ 3,326,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.88% |  |
Margin | 4.25% | 5.13% |  |
Floor | 12.00% | 9.55% |  |
Ceiling | 0.00% | 13.50% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2028 | May 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 2,000,000 |  |
Investments at cost | 4,963,000 | 1,996,000 |  |
Investments at fair value | $ 4,963,000 | $ 1,996,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.88% |  |
Margin | 4.25% | 5.13% |  |
Floor | 12.00% | 9.55% |  |
Ceiling | 0.00% | 13.50% |  |
ETP | 4.00% | 5.50% |  |
Maturity Date | Mar. 01, 2028 | May 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 3,333,000 |  |
Investments at cost | 4,963,000 | 3,326,000 |  |
Investments at fair value | $ 4,963,000 | $ 3,326,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate |  | 12.88% |  |
Margin |  | 5.13% |  |
Floor |  | 9.55% |  |
Ceiling |  | 13.50% |  |
ETP |  | 5.50% |  |
Maturity Date |  | May 01, 2026 |  |
Principal Amount |  | $ 3,333,000 |  |
Investments at cost |  | 3,326,000 |  |
Investments at fair value |  | $ 3,326,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Castle Creek Biosciences, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate |  | 12.88% |  |
Margin |  | 5.13% |  |
Floor |  | 9.55% |  |
Ceiling |  | 13.50% |  |
ETP |  | 5.50% |  |
Maturity Date |  | May 01, 2026 |  |
Principal Amount |  | $ 2,000,000 |  |
Investments at cost |  | 1,996,000 |  |
Investments at fair value |  | $ 1,996,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.22% | 12.22% |  |
Margin | 4.72% | 4.72% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Nov. 01, 2025 | Nov. 01, 2025 |  |
Principal Amount | $ 2,917,000 | $ 4,167,000 |  |
Investments at cost | 2,901,000 | 4,144,000 |  |
Investments at fair value | 2,901,000 | 4,144,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 176,000 | 176,000 |  |
Investments at fair value | $ 453,000 | $ 129,000 |  |
Number of Shares (in shares) | 110,402 | 110,402 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Emalex Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.22% | 12.22% |  |
Margin | 4.72% | 4.72% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,981,000 | 4,982,000 |  |
Investments at fair value | 4,981,000 | 4,982,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Imunon, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 65,000 | 65,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 19,671 | 19,671 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.25% | 12.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 10.75% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.50% |  |
Maturity Date | Apr. 01, 2030 | May 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 6,250,000 |  |
Investments at cost | 4,983,000 | 6,220,000 |  |
Investments at fair value | 4,983,000 | 6,220,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 118,000 | 50,000 |  |
Investments at fair value | $ 126,000 | $ 53,000 |  |
Number of Shares (in shares) | 105,768 | 48,076 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.25% | 12.25% |  |
Margin | 4.75% | 4.75% |  |
Floor | 10.75% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.50% |  |
Maturity Date | Apr. 01, 2030 | May 01, 2027 |  |
Principal Amount | $ 5,000,000 | $ 6,250,000 |  |
Investments at cost | 4,983,000 | 6,220,000 |  |
Investments at fair value | $ 4,983,000 | 6,220,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.25% |  |  |
Margin | 4.75% |  |  |
Floor | 10.75% |  |  |
Ceiling | 0.00% |  |  |
ETP | 5.00% |  |  |
Maturity Date | Apr. 01, 2030 |  |  |
Principal Amount | $ 5,000,000 |  |  |
Investments at cost | 4,983,000 |  |  |
Investments at fair value | $ 4,983,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | KSQ Therapeutics, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.25% |  |  |
Margin | 3.75% |  |  |
Floor | 10.75% |  |  |
Ceiling | 0.00% |  |  |
ETP | 5.00% |  |  |
Maturity Date | Apr. 01, 2030 |  |  |
Principal Amount | $ 5,000,000 |  |  |
Investments at cost | 4,983,000 |  |  |
Investments at fair value | 4,983,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Mustang Bio, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 146,000 | 146,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 568 | 16,611 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026 |  |
Principal Amount | $ 2,500,000 | $ 2,875,000 |  |
Investments at cost | 2,490,000 | 2,862,000 |  |
Investments at fair value | 2,490,000 | 2,862,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 73,000 | 73,000 |  |
Investments at fair value | $ 66,000 | $ 68,000 |  |
Number of Shares (in shares) | 112,879 | 112,879 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Native Microbials, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.75% | 12.75% |  |
Margin | 5.25% | 5.25% |  |
Floor | 8.50% | 8.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Nov. 01, 2026 | Nov. 01, 2026 |  |
Principal Amount | $ 1,667,000 | $ 1,917,000 |  |
Investments at cost | 1,659,000 | 1,906,000 |  |
Investments at fair value | $ 1,659,000 | $ 1,906,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026 |  |
Principal Amount | $ 7,500,000 | $ 8,750,000 |  |
Investments at cost | 7,472,000 | 8,712,000 |  |
Investments at fair value | 7,472,000 | 8,712,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 160,000 | 160,000 |  |
Investments at fair value | $ 2,000 | $ 14,000 |  |
Number of Shares (in shares) | 299,848 | 299,848 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026 |  |
Principal Amount | $ 2,813,000 | $ 3,281,000 |  |
Investments at cost | 2,802,000 | 3,267,000 |  |
Investments at fair value | $ 2,802,000 | $ 3,267,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | PDS Biotechnology Corporation [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.75% | 9.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.75% | 3.75% |  |
Maturity Date | Sep. 01, 2026 | Sep. 01, 2026 |  |
Principal Amount | $ 2,813,000 | $ 3,281,000 |  |
Investments at cost | 2,802,000 | 3,267,000 |  |
Investments at fair value | $ 2,802,000 | $ 3,267,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.86% | 12.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.30% | 4.30% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 3,482,000 | $ 3,482,000 |  |
Investments at cost | 3,426,000 | 3,418,000 |  |
Investments at fair value | 2,965,000 | 3,182,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 278,000 | 278,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 175,098 | 175,098 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 312,000 | $ 312,000 |  |
Investments at fair value | $ 32,000 | $ 59,000 |  |
Number of Shares (in shares) | 709,980 | 709,980 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.86% | 12.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.30% | 4.30% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 3,482,000 | $ 3,482,000 |  |
Investments at cost | 3,426,000 | 3,418,000 |  |
Investments at fair value | $ 2,965,000 | $ 3,182,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.86% | 12.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.31% | 4.31% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 1,741,000 | $ 1,741,000 |  |
Investments at cost | 1,710,000 | 1,705,000 |  |
Investments at fair value | $ 1,480,000 | $ 1,588,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.86% | 12.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.31% | 4.31% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 1,741,000 | $ 1,741,000 |  |
Investments at cost | 1,710,000 | 1,705,000 |  |
Investments at fair value | $ 1,480,000 | $ 1,588,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 12.86% | 12.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.31% | 4.31% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 1,741,000 | $ 1,741,000 |  |
Investments at cost | 1,708,000 | 1,704,000 |  |
Investments at fair value | $ 1,480,000 | $ 1,587,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Provivi, Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 12.86% | 12.86% |  |
Margin | 5.36% | 5.36% |  |
Floor | 9.50% | 9.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.31% | 4.31% |  |
Maturity Date | Jan. 01, 2027 | Jan. 01, 2027 |  |
Principal Amount | $ 1,741,000 | $ 1,741,000 |  |
Investments at cost | 1,708,000 | 1,704,000 |  |
Investments at fair value | $ 1,480,000 | $ 1,587,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 667,000 | $ 1,000,000 |  |
Investments at cost | 652,000 | 971,000 |  |
Investments at fair value | $ 652,000 | $ 971,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Greenlight Biosciences, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.25% | 13.25% |  |
Margin | 5.75% | 5.75% |  |
Floor | 9.00% | 9.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.00% | 3.00% |  |
Maturity Date | Jul. 01, 2025 | Jul. 01, 2025 |  |
Principal Amount | $ 333,000 | $ 500,000 |  |
Investments at cost | 326,000 | 486,000 |  |
Investments at fair value | $ 326,000 | $ 486,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 8.75% | 8.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 6.00% | 6.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 1,417,000 | $ 2,024,000 |  |
Investments at cost | 1,400,000 | 1,999,000 |  |
Investments at fair value | 1,400,000 | 1,999,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 264,000 | 264,000 |  |
Investments at fair value | $ 23,000 | $ 0 |  |
Number of Shares (in shares) | 318,181 | 318,181 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Stealth BioTherapeutics Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 8.75% | 8.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 6.00% | 6.00% |  |
Maturity Date | Oct. 01, 2025 | Oct. 01, 2025 |  |
Principal Amount | $ 708,000 | $ 1,012,000 |  |
Investments at cost | 700,000 | 1,000,000 |  |
Investments at fair value | $ 700,000 | $ 1,000,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 14.00% | 4.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,475,000 | 2,471,000 |  |
Investments at fair value | 2,356,000 | 2,471,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 198,000 | 194,000 |  |
Investments at fair value | $ 15,000 | $ 167,000 |  |
Number of Shares (in shares) | 2,266,669 | 1,600,002 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Tallac Therapeutics, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.25% | 12.25% |  |
Margin | 4.25% | 4.25% |  |
Floor | 12.25% | 12.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 14.00% | 4.00% |  |
Maturity Date | Aug. 01, 2027 | Aug. 01, 2027 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,475,000 | 2,471,000 |  |
Investments at fair value | 2,356,000 | 2,471,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Xeris Pharmaceuticals, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 73,000 | 73,000 |  |
Investments at fair value | $ 329,000 | $ 91,000 |  |
Number of Shares (in shares) | 126,000 | 126,000 |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Long Grove Pharmaceuticals, LLC [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Investments at fair value | $ 9,814,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Biotechnology Sector [Member] | Long Grove Pharmaceuticals, LLC [Member] | Term Loan, SOFR Index, One [Member] |  |  |  |
Cash Rate | 8.32% |  |  |
Margin | 4.00% |  |  |
Floor | 6.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 0.00% |  |  |
Maturity Date | Feb. 27, 2031 |  |  |
Principal Amount | $ 10,037,000 |  |  |
Investments at cost | 9,814,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Warrant [Member] |  |  |  |
Investments at cost | 5,290,000 | $ 5,149,000 |  |
Investments at fair value | 6,351,000 | 6,374,000 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 287,787,000 |  |  |
Investments at fair value | 284,327,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Magnolia Medical Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 194,000 | 194,000 |  |
Investments at fair value | $ 550,000 | $ 368,000 |  |
Number of Shares (in shares) | 900,043 | 809,931 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | VERO Biotech LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 379,000 | $ 376,000 |  |
Investments at fair value | $ 192,000 | $ 198,000 |  |
Number of Shares (in shares) | 3,701 | 3,701 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Meditrina, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 83,000 | $ 83,000 |  |
Investments at fair value | $ 33,000 | $ 34,000 |  |
Number of Shares (in shares) | 233,993 | 233,993 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | MicroTransponder, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 47,000 | $ 47,000 |  |
Investments at fair value | $ 50,000 | $ 66,000 |  |
Number of Shares (in shares) | 103,172 | 103,172 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Onkos Surgical, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 192,000 | $ 192,000 |  |
Investments at fair value | $ 187,000 | $ 187,000 |  |
Number of Shares (in shares) | 443,674 | 443,674 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Scientia Vascular, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 103,000 | $ 103,000 |  |
Investments at fair value | $ 426,000 | $ 262,000 |  |
Number of Shares (in shares) | 34,410 | 34,410 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Sonex Health, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 275,000 | $ 275,000 |  |
Investments at fair value | $ 260,000 | $ 266,000 |  |
Number of Shares (in shares) | 2,637,133 | 2,637,133 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Spineology, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 143,000 | $ 143,000 |  |
Investments at fair value | $ 108,000 | $ 108,000 |  |
Number of Shares (in shares) | 27,139 | 2,714,033 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Spineology, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 17,000 | $ 16,000 |  |
Investments at fair value | $ 29,000 | $ 28,000 |  |
Number of Shares (in shares) | 22,551 | 2,255,155 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Lumithera, Inc. [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost | $ 1,146,000 | $ 1,146,000 |  |
Investments at fair value | 100,000 | 100,000 |  |
Investment, Unaffiliated Issuer [Member] | Life Science Segment [Member] | Robin Healthcare, Inc. [Member] | Royalty Agreement [Member] |  |  |  |
Investments at cost | 7,331,000 | 7,319,000 |  |
Investments at fair value | 0 | 0 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] |  |  |  |
Investments at cost |  | 8,918,000 |  |
Investments at fair value |  | 10,650,000 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Warrant [Member] |  |  |  |
Investments at cost | 8,943,000 |  |  |
Investments at fair value | 10,643,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 218,806,000 | 222,699,000 |  |
Investments at fair value | 187,791,000 | 198,350,000 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Havenly, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | 3,178,000 | 3,178,000 |  |
Investments at fair value | $ 3,107,000 | $ 3,106,000 |  |
Number of Shares (in shares) | 1,446,429 | 1,446,429 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Kodiak Robotics, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 273,000 | $ 273,000 |  |
Investments at fair value | $ 128,000 | $ 15,000 |  |
Number of Shares (in shares) | 639,918 | 639,918 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Noodle Partners, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 116,000 | $ 116,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 84,037 | 84,037 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | OneNetworks, Inc. dba Finexio [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 3,000 | $ 3,000 |  |
Investments at fair value | $ 3,000 | $ 3,000 |  |
Number of Shares (in shares) | 184,646 | 184,646 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Revinate Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 44,000 | $ 44,000 |  |
Investments at fair value | $ 88,000 | $ 90,000 |  |
Number of Shares (in shares) | 682,034 | 682,034 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | SIGNiX, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 225,000 | $ 225,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 186,235 | 186,235 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Mirantis, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 223,000 | $ 223,000 |  |
Investments at fair value | $ 576,000 | $ 585,000 |  |
Number of Shares (in shares) | 948,275 | 948,275 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Slingshot Aerospace, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 123,000 | $ 123,000 |  |
Investments at fair value | $ 51,000 | $ 66,000 |  |
Number of Shares (in shares) | 309,208 | 309,208 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 188,000 | $ 188,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 12,618 | 12,618 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | NextCar Holding Company, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 9,000 | $ 9,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 3,913,723 | 3,913,723 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Supply Network Visiblity Holdings LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 64,000 | $ 65,000 |  |
Investments at fair value | $ 73,000 | $ 75,000 |  |
Number of Shares (in shares) | 682 | 682 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Topia Mobility, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 138,000 | $ 138,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 30,496 | 30,496 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Ursa Space Systems Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 151,000 | $ 151,000 |  |
Investments at fair value | $ 144,000 | $ 148,000 |  |
Number of Shares (in shares) | 1,075,072 | 1,075,072 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Viken Detection Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 120,000 | $ 120,000 |  |
Investments at fair value | $ 375,000 | $ 234,000 |  |
Number of Shares (in shares) | 345,443 | 345,443 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | xAd, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 177,000 | $ 177,000 |  |
Investments at fair value | $ 6,000 | $ 6,000 |  |
Number of Shares (in shares) | 4,343,348 | 4,343,348 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Optoro, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 182,000 | $ 182,000 |  |
Investments at fair value | $ 100,000 | $ 99,000 |  |
Number of Shares (in shares) | 11,550 | 11,550 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Standvast Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 275,000 | $ 275,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 1,225,492 | 1,225,492 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Axiom Space, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 46,000 | $ 46,000 |  |
Investments at fair value | $ 24,000 | $ 35,000 |  |
Number of Shares (in shares) | 1,991 | 1,991 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Unagi, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 32,000 | $ 32,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 171,081 | 171,081 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Intelepeer Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 138,000 | $ 138,000 |  |
Investments at fair value | $ 3,144,000 | $ 3,156,000 |  |
Number of Shares (in shares) | 2,936,535 | 2,936,535 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Alula Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 93,000 | $ 93,000 |  |
Investments at fair value | $ 7,000 | $ 7,000 |  |
Number of Shares (in shares) | 20,000 | 20,000 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | CAMP NYC, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 36,000 | $ 36,000 |  |
Investments at fair value | $ 39,000 | $ 40,000 |  |
Number of Shares (in shares) | 112,356 | 112,356 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Fictiv, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 59,000 | $ 59,000 |  |
Investments at fair value | $ 73,000 | $ 77,000 |  |
Number of Shares (in shares) | 126,841 | 126,841 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Clara Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 30,000 | $ 30,000 |  |
Investments at fair value | $ 42,000 | $ 43,000 |  |
Number of Shares (in shares) | 46,745 | 46,745 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 79,000 | $ 79,000 |  |
Investments at fair value | $ 4,000 | $ 7,000 |  |
Number of Shares (in shares) | 9,801 | 9,801 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Divergent Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 454,000 | $ 454,000 |  |
Investments at fair value | $ 441,000 | $ 440,000 |  |
Number of Shares (in shares) | 45,273 | 45,273 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Britecore Holdings, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 98,000 | $ 98,000 |  |
Investments at fair value | $ 238,000 | $ 289,000 |  |
Number of Shares (in shares) | 161,215 | 161,215 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | MyForest Foods Co [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 29,000 | $ 29,000 |  |
Investments at fair value | $ 24,000 | $ 25,000 |  |
Number of Shares (in shares) | 250 | 250 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Crafty Holdings, Inc.[Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 132,000 | $ 132,000 |  |
Investments at fair value | $ 132,000 | $ 132,000 |  |
Number of Shares (in shares) | 243,278 | 243,278 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Primary Kids, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 57,000 | $ 57,000 |  |
Investments at fair value | $ 369,000 | $ 412,000 |  |
Number of Shares (in shares) | 553,778 | 553,778 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Quip NYC Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 325,000 | $ 325,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 6,191 | 6,191 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | DropOff, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 455,000 | $ 455,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 516,535 | 516,535 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Updater, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 34,000 | $ 34,000 |  |
Investments at fair value | $ 26,000 | $ 26,000 |  |
Number of Shares (in shares) | 108,333 | 108,333 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | CPG Beyond, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 242,000 | $ 242,000 |  |
Investments at fair value | $ 226,000 | $ 231,000 |  |
Number of Shares (in shares) | 500,000 | 500,000 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Silk, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 175,000 | $ 175,000 |  |
Investments at fair value | $ 96,000 | $ 119,000 |  |
Number of Shares (in shares) | 394,110 | 394,110 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Global Worldwide LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 75,000 | $ 75,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 245,810 | 245,810 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Rocket Lawyer Incorporated [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 92,000 | $ 92,000 |  |
Investments at fair value | $ 314,000 | $ 319,000 |  |
Number of Shares (in shares) | 261,721 | 261,721 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | HappyCo, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 26,000 |  |  |
Investments at fair value | $ 23,000 |  |  |
Number of Shares (in shares) | 96,228 |  |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Skillshare, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 162,000 | $ 162,000 |  |
Investments at fair value | $ 597,000 | $ 680,000 |  |
Number of Shares (in shares) | 139,074 | 139,074 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Liqid, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 364,000 | $ 364,000 |  |
Investments at fair value | $ 100,000 | $ 103,000 |  |
Number of Shares (in shares) | 344,102 | 344,102 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Avalanche Technology, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 45,000 | $ 45,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 5,938 | 5,938 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | E La Carte, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 60,000 | $ 60,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 147,361 | 147,361 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Everstream Holdings, LLC [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 82,000 | $ 82,000 |  |
Investments at fair value | $ 26,000 | $ 34,000 |  |
Number of Shares (in shares) | 525,000 | 525,000 |  |
Investment, Unaffiliated Issuer [Member] | Technology Sector [Member] | Lemongrass Holdings, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 34,000 | $ 34,000 |  |
Investments at fair value | $ 47,000 | $ 48,000 |  |
Number of Shares (in shares) | 101,308 | 101,308 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Debt Securities [Member] |  |  |  |
Investments at cost |  | $ 67,637,000 |  |
Investments at fair value |  | $ 67,052,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Aerofarms, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.33% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 3,594,000 |  |
Investments at cost |  | 3,564,000 |  |
Investments at fair value |  | $ 3,564,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Aerofarms, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate |  | 14.25% |  |
Margin |  | 6.75% |  |
Floor |  | 10.00% |  |
Ceiling |  | 0.00% |  |
ETP |  | 4.33% |  |
Maturity Date |  | Dec. 01, 2026 |  |
Principal Amount |  | $ 3,594,000 |  |
Investments at cost |  | 3,564,000 |  |
Investments at fair value |  | $ 3,564,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% |  |  |
Margin | 6.75% |  |  |
Floor | 10.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 4.33% |  |  |
Maturity Date | Dec. 01, 2026 |  |  |
Principal Amount | $ 3,125,000 |  |  |
Investments at cost | 3,102,000 |  |  |
Investments at fair value | $ 3,102,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 14.25% |  |  |
Margin | 6.75% |  |  |
Floor | 10.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 4.33% |  |  |
Maturity Date | Dec. 01, 2026 |  |  |
Principal Amount | $ 3,125,000 |  |  |
Investments at cost | 3,102,000 |  |  |
Investments at fair value | $ 3,102,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,941,000 | 4,922,000 |  |
Investments at fair value | $ 4,528,000 | $ 4,792,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Apr. 01, 2026 | Apr. 01, 2026 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,471,000 | 2,461,000 |  |
Investments at fair value | $ 2,264,000 | $ 2,396,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,941,000 | 4,922,000 |  |
Investments at fair value | $ 4,528,000 | $ 4,792,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | May 01, 2026 | May 01, 2026 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,470,000 | 2,461,000 |  |
Investments at fair value | $ 2,264,000 | $ 2,396,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,939,000 | 4,925,000 |  |
Investments at fair value | $ 4,526,000 | $ 4,795,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Soli Organic, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 13.00% | 13.00% |  |
Margin | 5.50% | 5.50% |  |
Floor | 11.75% | 11.75% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.75% | 2.75% |  |
Maturity Date | Dec. 01, 2026 | Dec. 01, 2026 |  |
Principal Amount | $ 2,500,000 | $ 2,500,000 |  |
Investments at cost | 2,469,000 | 2,462,000 |  |
Investments at fair value | $ 2,263,000 | $ 2,397,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,710,000 | 3,707,000 |  |
Investments at fair value | $ 3,710,000 | $ 3,707,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,710,000 | 3,707,000 |  |
Investments at fair value | $ 3,710,000 | $ 3,707,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 7,500,000 | $ 7,500,000 |  |
Investments at cost | 7,415,000 | 7,407,000 |  |
Investments at fair value | $ 7,415,000 | $ 7,407,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,708,000 | 3,704,000 |  |
Investments at fair value | $ 3,708,000 | $ 3,704,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 14.25% | 14.25% |  |
Margin | 6.75% | 6.75% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.50% | 2.50% |  |
Maturity Date | Apr. 01, 2028 | Apr. 01, 2028 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,708,000 | 3,704,000 |  |
Investments at fair value | $ 3,708,000 | $ 3,704,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 4,500,000 | $ 4,500,000 |  |
Investments at cost | 4,457,000 | 4,454,000 |  |
Investments at fair value | $ 4,457,000 | $ 4,454,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Sustainability Sector [Member] | Temperpack Technologies, Inc [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.00% | 2.00% |  |
Maturity Date | Jan. 01, 2029 | Jan. 01, 2029 |  |
Principal Amount | $ 2,000,000 | $ 2,000,000 |  |
Investments at cost | 1,981,000 | 1,980,000 |  |
Investments at fair value | $ 1,981,000 | $ 1,980,000 |  |
Investment, Unaffiliated Issuer [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.00% | 4.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Feb. 01, 2029 | Feb. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,745,000 | 4,742,000 |  |
Investments at fair value | $ 4,745,000 | $ 4,742,000 |  |
Investment, Unaffiliated Issuer [Member] | Energy Efficiency [Member] | Pivot Bio, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 4.00% | 4.00% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Feb. 01, 2029 | Feb. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,954,000 | 4,951,000 |  |
Investments at fair value | 4,954,000 | 4,951,000 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Warrant [Member] |  |  |  |
Investments at cost | 713,000 | 715,000 |  |
Investments at fair value | 153,000 | 187,000 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 66,823,000 |  |  |
Investments at fair value | 64,965,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Pivot Bio, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 14,000 | 14,000 |  |
Investments at fair value | $ 10,000 | $ 14,000 |  |
Number of Shares (in shares) | 210,418 | 210,418 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | New Aerofarms, Inc. assignee of Aerofarms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 81,000 | $ 82,000 |  |
Investments at fair value | $ 12,000 | $ 17,000 |  |
Number of Shares (in shares) | 400,000 | 400,000 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 20,000 | $ 20,000 |  |
Investments at fair value | $ 0 | $ 19,000 |  |
Number of Shares (in shares) | 296 | 296 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Soli Organic, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 382,000 | $ 382,000 |  |
Investments at fair value | $ 9,000 | $ 10,000 |  |
Number of Shares (in shares) | 1,075 | 1,075 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | LiquiGlide, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 38,000 | $ 39,000 |  |
Investments at fair value | $ 23,000 | $ 25,000 |  |
Number of Shares (in shares) | 61,359 | 61,359 |  |
Investment, Unaffiliated Issuer [Member] | Sustainability Segment [Member] | Temperpack Technologies, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 178,000 | $ 178,000 |  |
Investments at fair value | $ 99,000 | $ 102,000 |  |
Number of Shares (in shares) | 49,693 | 49,693 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2029 | Oct. 01, 2029 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,597,000 | 3,595,000 |  |
Investments at fair value | $ 3,597,000 | $ 3,595,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2029 | Oct. 01, 2029 |  |
Principal Amount | $ 3,750,000 | $ 3,750,000 |  |
Investments at cost | 3,697,000 | 3,695,000 |  |
Investments at fair value | $ 3,697,000 | $ 3,695,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | GT Medical Technologies, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Oct. 01, 2029 | Oct. 01, 2029 |  |
Principal Amount | $ 7,500,000 | $ 7,500,000 |  |
Investments at cost | 7,394,000 | 7,389,000 |  |
Investments at fair value | $ 7,394,000 | $ 7,389,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,856,000 | 4,854,000 |  |
Investments at fair value | $ 4,856,000 | $ 4,854,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,956,000 | 4,954,000 |  |
Investments at fair value | $ 4,956,000 | $ 4,954,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,956,000 | 4,954,000 |  |
Investments at fair value | $ 4,956,000 | $ 4,954,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,956,000 | 4,954,000 |  |
Investments at fair value | $ 4,956,000 | $ 4,954,000 |  |
Investment, Unaffiliated Issuer [Member] | Other Healthcare Sector [Member] | Hometeam Technologies, Inc [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 11.25% | 11.25% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.25% | 11.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,956,000 | 4,954,000 |  |
Investments at fair value | 4,956,000 | 4,954,000 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Warrant [Member] |  |  |  |
Investments at cost | 1,047,000 | 1,047,000 |  |
Investments at fair value | 1,456,000 | 1,066,000 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 107,566,000 | 106,940,000 |  |
Investments at fair value | 104,815,000 | 104,189,000 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | BrightInsight, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | 167,000 | 167,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 85,066 | 85,066 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Elligo Healthcare Research, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 191,000 | $ 191,000 |  |
Investments at fair value | $ 72,000 | $ 92,000 |  |
Number of Shares (in shares) | 652,250 | 652,250 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | SafelyYou, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 163,000 | $ 163,000 |  |
Investments at fair value | $ 144,000 | $ 149,000 |  |
Number of Shares (in shares) | 206,983 | 150,353 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | GT Medical Technologies, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 83,000 | $ 83,000 |  |
Investments at fair value | $ 93,000 | $ 95,000 |  |
Number of Shares (in shares) | 195,984 | 195,984 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Hound Labs, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 45,000 | $ 45,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 451,796 | 451,796 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] | Common Stock Warrants [Member] |  |  |  |
Investments at cost | $ 71,000 | $ 71,000 |  |
Investments at fair value | $ 96,000 | $ 15,000 |  |
Number of Shares (in shares) | 32,244 | 32,244 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Parse Biosciences, Inc. [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 166,000 | $ 166,000 |  |
Investments at fair value | $ 346,000 | $ 15,000 |  |
Number of Shares (in shares) | 184,253 | 184,253 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Kate Farms, Inc [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 101,000 | $ 101,000 |  |
Investments at fair value | $ 705,000 | $ 700,000 |  |
Number of Shares (in shares) | 82,965 | 82,965 |  |
Investment, Unaffiliated Issuer [Member] | Healthcare Information and Services Segment [Member] | Medsphere Systems Corporation [Member] | Preferred Stock Warrants [Member] |  |  |  |
Investments at cost | $ 60,000 | $ 60,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 7,097,792 | 7,097,792 |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.00% | 10.88% |  |
Margin | 3.50% | 3.375% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2029 | Apr. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,709,000 | 4,706,000 |  |
Investments at fair value | $ 4,709,000 | $ 4,706,000 |  |
Investment, Unaffiliated Issuer [Member] | Networking Sector [Member] | Fictiv, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.00% | 10.88% |  |
Margin | 3.50% | 3.375% |  |
Floor | 10.00% | 10.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 4.00% | 4.00% |  |
Maturity Date | Apr. 01, 2029 | Apr. 01, 2029 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,944,000 | 4,941,000 |  |
Investments at fair value | $ 4,944,000 | $ 4,941,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 1,929,000 | $ 1,607,000 |  |
Investments at cost | 300,000 | 1,576,000 |  |
Investments at fair value | $ 187,000 | $ 943,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 1,607,000 | $ 1,607,000 |  |
Investments at cost | 1,575,000 | 1,576,000 |  |
Investments at fair value | $ 982,000 | $ 943,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 13.50% | 13.50% |  |
Margin | 6.00% | 6.00% |  |
Floor | 9.25% | 9.25% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 3.50% |  |
Maturity Date | Jun. 01, 2026 | Jun. 01, 2026 |  |
Principal Amount | $ 1,607,000 | $ 3,214,000 |  |
Investments at cost | 1,575,000 | 3,151,000 |  |
Investments at fair value | $ 982,000 | $ 1,886,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 13.50% | 14.00% |  |
Margin | 6.00% | 0.00% |  |
Floor | 9.25% | 0.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 50.00% |  |
Maturity Date | Jun. 01, 2026 | Mar. 01, 2025 |  |
Principal Amount | $ 964,000 | $ 300,000 |  |
Investments at cost | 150,000 | 300,000 |  |
Investments at fair value | $ 93,000 | $ 180,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 13.50% | 14.00% |  |
Margin | 6.00% | 0.00% |  |
Floor | 9.25% | 0.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 3.50% | 100.00% |  |
Maturity Date | Jun. 01, 2026 | Mar. 01, 2025 |  |
Principal Amount | $ 3,214,000 | $ 250,000 |  |
Investments at cost | 3,152,000 | 250,000 |  |
Investments at fair value | $ 1,964,000 | $ 150,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index One [Member] |  |  |  |
Cash Rate | 14.00% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 50.00% |  |  |
Maturity Date | Mar. 01, 2025 |  |  |
Principal Amount | $ 300,000 |  |  |
Investments at cost | 300,000 |  |  |
Investments at fair value | $ 187,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Hound Labs, Inc. [Member] | Term Loan, Fixed Index Two [Member] |  |  |  |
Cash Rate | 14.00% |  |  |
Margin | 0.00% |  |  |
Floor | 0.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 100.00% |  |  |
Maturity Date | Mar. 01, 2025 |  |  |
Principal Amount | $ 250,000 |  |  |
Investments at cost | 250,000 |  |  |
Investments at fair value | $ 156,000 |  |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 11.50% | 11.50% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,750,000 | 4,659,000 |  |
Investments at fair value | $ 4,750,000 | $ 4,659,000 |  |
Investment, Unaffiliated Issuer [Member] | Diagnostics Sector [Member] | Parse Biosciences, Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 11.50% | 11.50% |  |
Margin | 3.25% | 3.25% |  |
Floor | 11.50% | 11.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 5.00% | 5.00% |  |
Maturity Date | Jan. 01, 2028 | Jan. 01, 2028 |  |
Principal Amount | $ 5,000,000 | $ 5,000,000 |  |
Investments at cost | 4,918,000 | 4,910,000 |  |
Investments at fair value | 4,918,000 | $ 4,910,000 |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,731,000 |  |
Investments at fair value |  | $ 3,731,000 |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,731,000 |  |
Investments at fair value |  | $ 3,731,000 |  |
Investment, Unaffiliated Issuer [Member] | Communications Sector [Member] | Axiom Space, Inc [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate |  | 13.75% |  |
Margin |  | 6.00% |  |
Floor |  | 9.25% |  |
Ceiling |  | 0.00% |  |
ETP |  | 2.50% |  |
Maturity Date |  | Jun. 01, 2026 |  |
Principal Amount |  | $ 3,750,000 |  |
Investments at cost |  | 3,731,000 |  |
Investments at fair value |  | 3,731,000 |  |
Investment, Affiliated Issuer, Controlled [Member] |  |  |  |
Investments at cost | 47,948,000 | 44,780,000 |  |
Investments at fair value | 14,869,000 | 31,819,000 | $ 13,644,000 | $ 14,223,000
Investment, Affiliated Issuer, Controlled [Member] | Equity Securities [Member] |  |  |  |
Investments at cost | 23,289,000 | 21,289,000 |  |
Investments at fair value | 7,910,000 | 17,921,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Debt Securities [Member] |  |  |  |
Investments at cost | 18,779,000 | 17,611,000 |  |
Investments at fair value | 1,669,000 | 7,668,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Investments [Member] |  |  |  |
Investments at cost | 5,880,000 | 5,880,000 |  |
Investments at fair value | 5,290,000 | 6,230,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Better Place Forests Co. [Member] |  |  |  |
Investments at fair value | 879,000 | 0 | 7,799,000 | 7,993,000
Investment, Affiliated Issuer, Controlled [Member] | Nexii Building Solutions, Inc [Member] |  |  |  |
Investments at fair value | 8,700,000 | 8,547,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Swift Health Systems Inc. [Member] |  |  |  |
Investments at fair value | 0 | 17,042,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | HIMV LLC [Member] |  |  |  |
Investments at fair value | $ 5,290,000 | $ 6,230,000 | 5,845,000 | 6,230,000
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 10.00% | 10.25% |  |
Margin | 2.50% | 2.50% |  |
Floor | 2.50% | 2.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 9.14% | 9.14% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 1,997,000 | $ 1,948,000 |  |
Investments at cost | 1,986,000 | 1,925,000 |  |
Investments at fair value | $ 0 | $ 1,658,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 10.00% | 10.25% |  |
Margin | 2.50% | 2.50% |  |
Floor | 2.50% | 2.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 9.14% | 9.14% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 1,997,000 | $ 1,948,000 |  |
Investments at cost | 1,977,000 | 1,925,000 |  |
Investments at fair value | $ 0 | $ 1,658,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 10.00% | 10.25% |  |
Margin | 2.50% | 2.50% |  |
Floor | 2.50% | 2.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 9.14% | 9.14% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 1,997,000 | $ 1,948,000 |  |
Investments at cost | 1,973,000 | 1,922,000 |  |
Investments at fair value | $ 0 | $ 1,654,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 10.00% | 10.25% |  |
Margin | 2.50% | 2.50% |  |
Floor | 2.50% | 2.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 9.14% | 9.14% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 1,997,000 | $ 1,948,000 |  |
Investments at cost | 1,973,000 | 1,922,000 |  |
Investments at fair value | 0 | 1,654,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | 12,012,000 | 10,012 |  |
Investments at fair value | $ 0 | $ 10,012 |  |
Number of Shares (in shares) | 4,233,666 | 3,588,505 |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 10.00% | 10.25% |  |
Margin | 2.50% | 2.50% |  |
Floor | 2.50% | 2.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 100.00% | 100.00% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 323,000 | $ 315,000 |  |
Investments at cost | 323,000 | 315,000 |  |
Investments at fair value | $ 0 | $ 271,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Medical Device Sector [Member] | Swift Health Systems Inc. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 10.00% | 10.25% |  |
Margin | 2.50% | 2.50% |  |
Floor | 2.50% | 2.50% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 100.00% | 100.00% |  |
Maturity Date | Jun. 01, 2028 | Jun. 01, 2028 |  |
Principal Amount | $ 160,000 | $ 156,000 |  |
Investments at cost | 160,000 | 156,000 |  |
Investments at fair value | $ 0 | $ 135,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, One [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.78% | 2.78% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 4,133,000 | $ 4,012,000 |  |
Investments at cost | 4,160,000 | 4,058,000 |  |
Investments at fair value | 381,000 | 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 639,000 | 639,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 2,278,272 | 2,278,272 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Two [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 2.78% | 2.78% |  |
Maturity Date | Aug. 01, 2029 | Aug. 01, 2029 |  |
Principal Amount | $ 2,067,000 | $ 2,006,000 |  |
Investments at cost | 1,989,000 | 1,989,000 |  |
Investments at fair value | $ 182,000 | $ 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Three [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 554,000 | $ 538,000 |  |
Investments at cost | 538,000 | 538,000 |  |
Investments at fair value | $ 49,000 | $ 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Four [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 548,000 | $ 532,000 |  |
Investments at cost | 532,000 | 532,000 |  |
Investments at fair value | 49,000 | 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | 3,922,000 | 3,922,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 5,350,142 | 5,350,142 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Five [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 537,000 | $ 521,000 |  |
Investments at cost | 521,000 | 521,000 |  |
Investments at fair value | $ 48,000 | $ 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Six [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 528,000 | $ 513,000 |  |
Investments at cost | 513,000 | 513,000 |  |
Investments at fair value | $ 47,000 | $ 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Seven [Member] |  |  |  |
Cash Rate | 12.00% | 12.00% |  |
Margin | 3.75% | 3.75% |  |
Floor | 12.00% | 12.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Aug. 01, 2025 | Aug. 01, 2025 |  |
Principal Amount | $ 520,000 | $ 505,000 |  |
Investments at cost | 505,000 | 505,000 |  |
Investments at fair value | $ 46,000 | 0 |  |
Investment, Affiliated Issuer, Controlled [Member] | Consumer-related Technologies [Member] | Better Place Forests Co. [Member] | Term Loan, Prime Index, Eight [Member] |  |  |  |
Cash Rate | 12.00% |  |  |
Margin | 3.75% |  |  |
Floor | 12.00% |  |  |
Ceiling | 0.00% |  |  |
ETP | 100.00% |  |  |
Maturity Date | Aug. 01, 2025 |  |  |
Principal Amount | $ 848,000 |  |  |
Investments at cost | 839,000 |  |  |
Investments at fair value | 77,000 |  |  |
Investment, Affiliated Issuer, Controlled [Member] | Biotechnology Sector [Member] | HIMV LLC [Member] | Other Investments [Member] |  |  |  |
Investments at cost | 5,880,000 | 5,880,000 |  |
Investments at fair value | 5,290,000 | 6,230,000 |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 3,297,000 | 3,297,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 108,320 | 108,320 |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Preferred Stock [Member] |  |  |  |
Investments at cost | $ 3,419,000 | $ 3,419,000 |  |
Investments at fair value | $ 7,910,000 | $ 7,909,000 |  |
Number of Shares (in shares) | 542 | 542 |  |
Investment, Affiliated Issuer, Controlled [Member] | Other Sustainability Sector [Member] | Nexii Building Solutions, Inc [Member] | Debt Securities [Member] |  |  |  |
Cash Rate | 10.00% | 10.00% |  |
Floor | 0.00% | 0.00% |  |
Ceiling | 0.00% | 0.00% |  |
ETP | 0.00% | 0.00% |  |
Maturity Date | Jul. 01, 2027 | Jul. 01, 2027 |  |
Principal Amount | $ 790,000 | $ 790,000 |  |
Investments at cost | 790,000 | 790,000 |  |
Investments at fair value | 790,000 | 638,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] |  |  |  |
Investments at cost | 27,493,000 | 27,491,000 |  |
Investments at fair value | 8,307,000 | 8,307,000 | 12,577,000 | 1,132,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Equity Securities [Member] |  |  |  |
Investments at cost | 5,000,000 | 5,000,000 |  |
Investments at fair value | 0 | 0 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Warrant [Member] |  |  |  |
Investments at cost | 127,000 | 127,000 |  |
Investments at fair value | 0 | 0 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Other Investments [Member] |  |  |  |
Investments at cost | 22,366,000 | 22,364,000 |  |
Investments at fair value | 8,307,000 | 8,307,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Evelo Biosciences, Inc. [Member] |  |  |  |
Investments at fair value | 8,307,000 | 8,307,000 | 12,577,000 | 1,132,000
Investment, Affiliated Issuer, Noncontrolled [Member] | Aulea Medical, Inc. [Member] |  |  |  |
Investments at fair value | 0 | 0 | $ 0 | $ 0
Investment, Affiliated Issuer, Noncontrolled [Member] | Medical Device Sector [Member] | Aulea Medical, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 0 | 0 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 660,537 | 660,537 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, One [Member] |  |  |  |
Investments at cost | $ 4,910,000 | $ 4,910,000 |  |
Investments at fair value | 1,825,000 | 1,825,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Common Stock [Member] |  |  |  |
Investments at cost | 5,000,000 | 5,000,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 2,164,502 | 2,164,502 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Two [Member] |  |  |  |
Investments at cost | $ 7,636,000 | $ 7,634,000 |  |
Investments at fair value | 2,832,000 | 2,832,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Three [Member] |  |  |  |
Investments at cost | 2,946,000 | 2,946,000 |  |
Investments at fair value | 1,095,000 | 1,095,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Four [Member] |  |  |  |
Investments at cost | 2,946,000 | 2,946,000 |  |
Investments at fair value | 1,095,000 | 1,095,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Warrant [Member] |  |  |  |
Investments at cost | 127,000 | 127,000 |  |
Investments at fair value | $ 0 | $ 0 |  |
Number of Shares (in shares) | 23,196 | 23,196 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Five [Member] |  |  |  |
Investments at cost | $ 1,964,000 | $ 1,964,000 |  |
Investments at fair value | 730,000 | 730,000 |  |
Investment, Affiliated Issuer, Noncontrolled [Member] | Biotechnology Sector [Member] | Evelo Biosciences, Inc. [Member] | Other Investments, Prime Index, Six [Member] |  |  |  |
Investments at cost | 1,964,000 | 1,964,000 |  |
Investments at fair value | $ 730,000 | $ 730,000 |  |

X
- Definition The ceiling rate of the investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedCeilingRate
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition The end of term payment rate (ETP) on investment owned. + References No definition available. + Details
Name: | hrzn_InvestmentOwnedEndOfTermPaymentsETP
Namespace Prefix: | hrzn_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Percentage added to reference rate used to compute variable rate on investment. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentBasisSpreadVariableRate
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Minimum rate of interest on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRateFloor
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Rate of interest paid in cash on investment. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentInterestRatePaidInCash
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | instant

X
- Definition Maturity date of investment, in YYYY-MM-DD format. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Subparagraph (f) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-5 Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 320 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -Publisher FASB -URI https://asc.fasb.org/1943274/2147481800/320-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SX 210.12-12A(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-2 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 4)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentMaturityDate
Namespace Prefix: | us-gaap_
Data Type: | xbrli:dateItemType
Balance Type: | na
Period Type: | instant

X
- Definition Cost of the investment. + References Reference 1: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 4: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 5: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 8)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 11)(a)(3)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 5)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 19 -Subparagraph (3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-19 + Details
Name: | us-gaap_InvestmentOwnedAtCost
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Fair value of investment in security owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(11)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 3: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (b)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-2 Reference 11: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 830 -Name Accounting Standards Codification -Section 55 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479168/946-830-55-12 Reference 12: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (a)(3) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.6-03(d)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479886/946-10-S99-3 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(a)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.6-04(2)(b)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479170/946-210-S99-1 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 18: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column A)(Footnote 1)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 19: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 20: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column C)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 21: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 22: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 23: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 6)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 24: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column A)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 25: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column C)(Footnote 9)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 26: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 27: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 28: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column A)(Footnote 1)(b)(5)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 29: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 4)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 Reference 30: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column F)(Footnote 7)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedAtFairValue
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Amount of principal of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalancePrincipalAmount
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | instant

X
- Definition Number of shares of investment owned. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 6 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-6 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 55 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477439/946-210-55-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 210 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478795/946-210-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.12-12(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-1 Reference 5: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 3 -Subparagraph (SX 210.12-12B(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-3 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 320 -Name Accounting Standards Codification -Section S99 -Paragraph 6 -Subparagraph (SX 210.12-14(Column B)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477271/946-320-S99-6 + Details
Name: | us-gaap_InvestmentOwnedBalanceShares
Namespace Prefix: | us-gaap_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | instant

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_UnrestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RestrictedShortTermInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_EquitySecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_WarrantMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_USBankMoneyMarketDepositAccountMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_MedicalDeviceSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SoftwareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_BiotechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherSustainabilitySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_EnergyEfficiencyMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_OtherHealthcareSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_NetworkingSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_DiagnosticsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_CommunicationsSectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentUnaffiliatedIssuerMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_DebtSecuritiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_OtherInvestmentsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CastleCreekBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_CommonStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EmalexBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NextcarHoldingCompanyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=us-gaap_PreferredStockMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AxiomSpaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CognoaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LumitheraIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CadrenalTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PebblepostIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CaastleIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GetaroundIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SnagajobcomIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TigoEnergyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DecisyonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LotameSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStock2Member
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CeribellIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_PreferredStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CandesantBiomedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VeroBiotechLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MicroTransponderIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ConventusOrthopaedicsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OnkosSurgicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ScientiaVascularIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_InfobionicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SonexHealthIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SpineologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MMLUSIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AccuveinIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_CommonStockWarrantsMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerinMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerobiotixLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentTypeAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CanaryMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CSAMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CVRXIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_ConsumerrelatedTechnologiesMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HavenlyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LyricalFoodsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexSevenMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanPrimeIndexEightMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OptoroIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StandvastHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UnagiIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KodiakRoboticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NoodlePartnersIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BrightinsightIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_OneNetworksIncdbaFinexioMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MirantisIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ElligoHealthcareResearchIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UrsaSpaceSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_VikenDetectionCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SafelyYouIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisibilityHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BritecoreHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CraftyHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DropOffIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HappyCoIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvaloTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ImunonIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KSQTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MustangBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NativeMicrobialsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PDSBiotechnologyCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ProviviIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GreenlightBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_StealthBioTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TallacTherapeuticsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XerisPharmaceuticalsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LongGrovePharmaceuticalLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanSofrIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_LifeScienceSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MagnoliaMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MeditrinaIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_RoyaltyAgreementMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RobinHealthcareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=us-gaap_TechnologySectorMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RevinateHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SignixIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SlingshotAerospaceIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SupplyNetworkVisiblityHoldingsLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TopiaMobilityIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_XadIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_IntelepeerHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AlulaHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CampNYCIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_FictivIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ClaraFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_DivergentTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MyforestFoodsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PrimaryKidsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_QuipNycIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_UpdaterIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_CPGBeyondIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SilkIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GlobalWorldwideLlcMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_RocketLawyerIncorporatedMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SkillshareIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiqidIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AvalancheTechnologyIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ELaCarteIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EverstreamHoldingsLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LemongrassHoldingsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NewAerofarmsIncAssigneeOfAerofarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SoliOrganicIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_TemperpackTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_PivotBioIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_SustainabilitySegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_LiquiglideIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_GTMedicalTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HometeamTechnologiesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_EquitySecuritiesByIndustryAxis=hrzn_HealthcareInformationAndServicesSegmentMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HoundLabsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_ParseBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_KateFarmsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_MedsphereSystemsCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_TermLoanFixedIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerControlledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_BetterPlaceForestsCoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_NexiiBuildingSolutionsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_SwiftHealthSystemsIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_HIMVLLCMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerAffiliationAxis=us-gaap_InvestmentAffiliatedIssuerNoncontrolledMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_EveloBiosciencesIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_InvestmentIssuerNameAxis=hrzn_AuleaMedicalIncMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexOneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexTwoMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexThreeMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFourMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexFiveMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_FinancialInstrumentAxis=hrzn_OtherInvestmentsPrimeIndexSixMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |